Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC125 | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-09 |
mRNA | HAVCR2 | GDSC1000 | pan-cancer | AAC | 0.32 | 4e-09 |
mRNA | PGC | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
mRNA | FAM129B | GDSC1000 | pan-cancer | AAC | 0.47 | 4e-09 |
mRNA | TMPRSS11F | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-09 |
mRNA | ATP6V0A4 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
mRNA | HGF | CCLE | pan-cancer | AAC | 0.27 | 7e-09 |
mRNA | PTPN7 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-09 |
mRNA | IL2RA | GDSC1000 | pan-cancer | AAC | 0.3 | 8e-09 |
mRNA | MTMR7 | GDSC1000 | pan-cancer | AAC | 0.31 | 8e-09 |